Nerve Agent Bioscavengers: Protection With Reduced Behavioral Effects

REFERENCES

• Ashani, Y., Shapira, S., Levy, D., Wolfe, A. D., Doctor, B. P., & Raveh, L. (1991). Butyryl-cholinesterase and acetylcholinesterase prophylaxis against soman poisoning in mice. Biochemical Pharmacology, 41, 37–41.
   PubMed Web of Science ®Google Scholar
• Bajgar, J., Jakl, A., & Hrdina, V. (1971). Influence of trimedoxime and atropine on acetylcholinesterase activity in some parts of the brain of mice poisoned by isopropylmethyl phosphonofluoridate. Biochemical Pharmacology, 20, 3230–3233.
   PubMed Web of Science ®Google Scholar
• Ballantyne, B., & Marrs, T. C. (1992). Overview of the biological and clinical aspects of organophosphates and carbamates. In B. Ballantyne & T. C. Marrs (Eds.), Clinical and experimental toxicology of organophosphates and carbamates (pp. 1–14). Oxford, England: Butterworth.
   Google Scholar
• Bismuth, C., Inns, R. H., & Marrs, T. C. (1992). Efficacy, toxicity and clinical use of oximes in anticholinesterase poisoning. In B. Ballantyne & T. C. Marrs (Eds.), Clinical and experimentaltoxi-cology of organophosphates and carbamates (pp. 555–577). Oxford, England: Butterworth.
   Google Scholar
• Blick, D. W., Murphy, M. R., Brown, G. C., Yochmowitz, M. G., Fanton, J. W., & Hartgraves, S. L. (1994). Acute behavioral toxicity of pyridostigmine or soman in primates. Toxicology and Applied Pharmacology, 126, 311–318.
   PubMed Web of Science ®Google Scholar
• Brandeis, R., Raveh, L., Grunwald, J., Cohen, E., & Ashani, Y. (1993). Prevention of soman-induced cognitive deficits by pretreatment with human butyrylcholinesterase in rats. Pharmacology, Biochemistry, and Behavior, 46, 889–896.
   PubMed Web of Science ®Google Scholar
• Brimblecombe, R. W. (1977). Drugs acting on central cholinergic mechanisms and affecting respiration. Pharmacology and Therapeutics, Part B: General and Systematic Pharmacology, 3, 65–74.
   PubMedGoogle Scholar
• Brimfield, A. A., Hunter, K. W., Lenz, D. E., Benschop, H. P., Van Dijk, C., & De Jong, L. P. A. (1985). Structural and stereochemical specificity of mouse monoclonal antibodies to the organophosphorus cholinesterase inhibitor soman. Molecular Pharmacology, 28, 32–39.
   PubMed Web of Science ®Google Scholar
• Brimfield, A. A., Lenz, D. E., Maxwell, D. M., & Broomfield, C. C. (1993). Catalytic antibodies hydro-lyzing organophosphorus esters. Chemico-Biological Interactions, 87, 95–102.
   PubMed Web of Science ®Google Scholar
• Broomfield, C. A. (1993). A purified recombinant organophosphorus acid anhydrase protects mice against soman. Chemico-Biological Interactions, 87, 279–284.
   PubMed Web of Science ®Google Scholar
• Broomfield, C. A., Maxwell, D. M., Solana, R. P., Castro, C. A., Finger, A. V., & Lenz, D. E. (1991). Protection of butyrylcholinesterase against organophosphorus poisoning in nonhuman primates. Journal of Pharmacology and Experimental Therapeutics, 259, 633–638.
   PubMed Web of Science ®Google Scholar
• Castro, C. A., Gresham, V. C., Finger, A. V., Maxwell, D. M., Solana, R. P., Lenz, D. E., et al. (1994). Behavioral decrements persist in rhesus monkeys trained on a serial probe recognition task despite protection against soman lethality by butyrylcholinesterase. Neurotoxicology and Teratology, 16, 145–148.
   PubMed Web of Science ®Google Scholar
• Castro, C. A., Larsen, T., Finger, A. V., Solana, R., & McMaster, S. B. (1991). Behavioral efficacy of di-azepam against nerve agent exposure in rhesus monkeys. Pharmacology, Biochemistry, and Behavior, 41, 159–164.
   Web of Science ®Google Scholar
• Chabrier, P. E., & Jacob, J. (1980). In vivo and in vitro inhibition of cholinesterase by methyl-1 (S methyl phosphoryl-3) imidazolium (MSPI), a model of an “instantly” aged phosphorylated enzyme. Archives of Toxicology, 45, 15–20.
   PubMed Web of Science ®Google Scholar
• Clement, J. G. (1982). HI-6 reactivation of central and peripheral acetylcholinesterase following inhibition by soman, sarin and tabun in vivo in the rat. Biochemical Pharmacology, 31, 1283–1287.
   PubMed Web of Science ®Google Scholar
• Dacre, J. C. (1984). Toxicology of some anticholinesterases used as chemical warfare agents—A review. In M. Brzin, E. A. Barnard, & D. Sket (Eds.), Cholinesterases, fundamental and applied aspects (pp. 415–426). Berlin, Germany: de Gruyter.
   Google Scholar
• de Candole, C. A., Douglas, W. W., Evans, C. L., Holmes, R., Spencer, K. E. V., Torrance, R. W., et al. (1953). The failure of respiration in death by anticholinesterase poisoning. British Journal of Pharmacology and Chemotherapy, 6, 466–475.
   Google Scholar
• Doctor, B. P., Blick, D. W., Caranto, G., Castro, C. A., Gentry, M. K., Larison, R., et al. (1993). Cholinesterases as scavengers for organophosphorus compounds: Protection of primate performance against soman toxicity. Chemico-Biological Interactions, 87, 285–293.
   PubMed Web of Science ®Google Scholar
• Doctor, B. P., Raveh, L., Wolfe, A. D., Maxwell, D. M., & Ashani, Y. (1991). Enzymes as pretreatment drugs for organophosphate toxicity. Neuroscience and Biobehavioral Reviews, 15, 123–128.
   PubMed Web of Science ®Google Scholar
• Dumas, D. P., Durst, H. D., Landis, W. G., Raushel, F. M., & Wild, J. R. (1990). Inactivation of organophosphorus nerve agents by the phosphotriesterase from Pseudomonasdiminuta. Archivesof Biochemistry and Biophysics, 277, 155–159.
   PubMed Web of Science ®Google Scholar
• Dunn, M. A., & Sidell, F. R. (1989). Progress in medical defense against nerve agents. Journal of the American Medical Association, 262, 649–652.
   PubMed Web of Science ®Google Scholar
• Ember, L. (1991, August 19). Chemical weapons: Plans prepared to destroy Iraqi arms. Chemical Engineering News, pp. 6–7.
   Web of Science ®Google Scholar
• Erdmann, W., Bosse, I., & Franke, P. (1965). Zur Resorption und Ausscheidung von Toxigonin nach Intramuskularer am Menschen [The absorption and elimination of toxigonin after intramuscular injection in humans]. Deutsche Medizinische Wochenschrift, 90, 1436–1438.
   PubMed Web of Science ®Google Scholar
• Fleisher, J. H., & Harris, L. W. (1965). Dealkylation as a mechanism for aging of cholinesterase after poisoning with pinacolyl methylphosphonofluoridate. Biochemical Pharmacology, 14, 641–650.
   PubMed Web of Science ®Google Scholar
• Gan, K. N., Smolen, A., Eckerson, H. W., & La Du, B. N. (1991). Purification of human serum paraoxonase/arylesterase. Drug Metabolism and Disposition, 19, 100–106.
   PubMed Web of Science ®Google Scholar
• Genovese, R. F., & Doctor, B. P. (1995). Behavioral and pharmacological assessment of butyrylcholinesterase in rats. Pharmacology, Biochemistry, and Behavior, 51, 647–654.
   PubMed Web of Science ®Google Scholar
• Gordon, J. J., Leadbeater, L., & Maidment, M. P. (1978). The protection of animals against organophosphorus poisoning by pretreatment with a carbamate. Toxicology and Applied Pharmacology, 43, 207–216.
   PubMed Web of Science ®Google Scholar
• Hale, G., Dyer, M. J. S., Clark, M. R., Phillips, J. M., Marcus, R., Reichmann, L., et al. (1988). Remission induction in non-Hodgkins lyphoma with reshaped human monoclonal antibody CAMPATH-1H. Lancet, 2 (8625), 1394–1399.
   PubMed Web of Science ®Google Scholar
• Heath, A. J. W., & Meredith, T. (1992). Atropine in the management of anticholinesterase poisoning. In B. Ballantyne & T. C. Marrs (Eds.), Clinical and experimental toxicology of organophosphates and carbamates (pp. 543–554). Oxford, England: Butterworth.
   Google Scholar
• Heffron, P. F., & Hobbinger, F. (1979). Relationship between inhibition of acetylcholinesterase and response of the rat phrenic nerve-diaphragm preparation to indirect stimulation at higher frequencies. British Journal of Pharmacology, 66, 323–329.
   PubMed Web of Science ®Google Scholar
• Huff, B. B. (Ed.). (1986). Physician's desk reference. Oradell, NJ: Medical Economics.
   Google Scholar
• Hunter, K. W., Lenz, D. E., Brimfield, A. A., & Naylor, J. A. (1982). Quantification of the organophosphorus nerve agent soman by competitive inhibition enzyme immunoassay using monoclonal antibodies. Federation of European Biochemical Societies Letters, 22 (149), 147–151.
   Google Scholar
• Koelle, G. B. (1963). Cholinesterases and anticholinesterase agents. In O. Eichler & A. Farah (Eds.), Handbuch der Experimentellen Pharmakologie (Vol. 15). Berlin, Germany: Springer-Verlag.
   Google Scholar
• Krueger, G. P., & Banderet, L. E. (1997). Effects of chemical protective clothing on military performance: A review of the issues. Military Psychology, 9, 251–253.
   Web of Science ®Google Scholar
• Leadbeater, L., Inns, R. H., & Rylands, J. M. (1985). Treatment of soman poisoning. Toxicology and Applied Pharmacology, 5 (6),Pt. 2, 225–231.
   Google Scholar
• Lenz, D. E., Brimfield, A. A., & Cook, L. A. (1997). The development of immunoassays for detection of chemical warfare agents. In D. Aga & E. M. Thurman (Eds.), Development and applications of immunoassays for environmental analysis (pp. 77–86). Washington, DC: ACS Books.
   Google Scholar
• Lenz, D. E., Brimfield, A. A., Hunter, K. W., Benschop, H. P., De Jong, L. P. A., Van Dijk, C., et al. (1984). Studies using a monoclonal antibody against soman. Fundamental and Applied Toxicology, 4 (2), Pt. 2, 156–164.
   Google Scholar
• Lockridge, O., Blong, R. M., Masson, P., Froment, M.-T., Millard, C. B., & Broomfield, C. A. (1997). A single amino acid substitution, Gly117His, confers phosphotriesterase (organophosphorus acid anhydride hydrolase) activity on human butyrylcholinesterase. Biochemistry, 36, 786–795.
   PubMed Web of Science ®Google Scholar
• Masson, P., Josse, D., Lockridge, O., Viguie, N., Taupin, C., & Buhler, C. (1998). Enzymes hydrolyzing organophosphates as potential catalytic scavengers against organophosphate poisoning. Journal of Physiology, 92, 357–362.
   Google Scholar
• Masuda, A. N., Takatsu, M., Morianari, H., & Ozawa, T. (1995). Sarin poisoning in Tokyo subway. Lancet, 345, 1446.
   PubMed Web of Science ®Google Scholar
• Matzke, S. M., Oubre, J. L., Caranto, G. R., Gentry, M. K., & Galbicka, G. (1999). Behavioral and im-munological effects of exogenous butyrylcholinesterase in rhesus monkeys. Pharmacology, Biochemistry, and Behavior, 62, 523–530.
   PubMed Web of Science ®Google Scholar
• Maxwell, D. M. (1992). The specificity of carboxylesterase protection against the toxicity of organophosphorus compounds. Toxicology and Applied Pharmacology, 114, 306–312.
   PubMed Web of Science ®Google Scholar
• Maxwell, D. M., Brecht, K. M., Doctor, B. P., & Wolfe, A. D. (1993). Comparison of antidote protection against soman by pyridostigmine, HI-6 and acetylcholinesterase. Journal of Pharmacology and Experimental Therapeutics, 264, 1085–1089.
   PubMed Web of Science ®Google Scholar
• Maxwell, D. M., Brecht, K. M., & O'Neill, B. L. (1987). The effect of carboxylesterase inhibition on interspecies differences in soman toxicity. Toxicology Letters, 39, 35–42.
   PubMed Web of Science ®Google Scholar
• Maxwell, D. M., Castro, C. A., DeLaHoz, D. M., Gentry, M. K., Gold, M. B., Solana, R. P., etal. (1992). Protection of rhesus monkeys against soman and prevention of performance decrement by pretreatment with acetylcholinesterase. Toxicology and Applied Pharmacology, 115, 44–49.
   PubMed Web of Science ®Google Scholar
• Maxwell, D. M., Wolfe, A. D., Ashani, Y., & Doctor, P. B. (1991). Cholinesterase and carboxylesterase as scavengers for organophosphorus agents. In F. Bacu (Ed.), Proceedings of the Third International Meeting on Cholinesterase (pp. 206–209). Washington, DC: ACS Books.
   Google Scholar
• Maynard, R. L., & Beswick, F. W. (1992). Organophosphorus compounds as chemical warfare agents. In B. Ballantyne & T. C. Marrs (Eds.), Clinical and experimental toxicology of organophosphates and carbamates (pp. 373–385). Oxford, England: Butterworth.
   Google Scholar
• McDonough, J. H. (2002/this issue). Performance impacts of nerve agents and their pharmacological countermeasures. Military Psychology, 14, 93–119.
   Web of Science ®Google Scholar
• McDonough, J. H., & Penetar, D. M. (1982). The effects of cholinergic blocking agents and anticholinesterase compounds on memory, learning and performance. In M. Y Spiegelstein & A. Levy (Eds.), Behavioral models and the analysis of drug action: Proceedings of the 27th OHOLO Conference (pp. 155–174). Amsterdam: Elsevier.
   Google Scholar
• Millard, C. B., Lockridge, O., & Broomfield, C. A. (1995). Design and expression of organophosphorus acid anhydride hydrolase activity in human butyrylcholinesterase. Biochemistry, 34, 15925–15933.
   PubMed Web of Science ®Google Scholar
• Millard, C. B., Lockridge, O., & Broomfield, C. A. (1998). Organophosphorus acid anhydride hydrolase activity inhuman butyrylcholinesterase: Synergy results in a somanase. Biochemistry, 37, 237–247.
   PubMed Web of Science ®Google Scholar
• Raveh, L., Grauer, E., Grunwald, J., Cohen, E., & Ashani, Y. (1997). The stoichiometry of protection against soman and VX toxicity in monkeys pretreated with human butyrylcholinesterase. Toxicology and Applied Pharmacology, 145, 43–53.
   PubMed Web of Science ®Google Scholar
• Raveh, L., Grunwald, J., Marcus, D., Papier, Y., Cohen, E., & Ashani, Y. (1993). Human butyrylcholinesterase as a general prophylactic antidote for nerve agent toxicity. Biochemical Pharmacology, 45, 2465–2474.
   PubMed Web of Science ®Google Scholar
• Reiner, E. (1971). Spontaneous reactivation of phosphorylated and carbamylated cholinesterases. Bulletin of the World Health Organization, 44, 109–112.
   PubMed Web of Science ®Google Scholar
• Sedar, C. M., & Gibson, D. T. (1985). Enzymatic hydrolysis of organophosphates: Cloning and expression of a parathion hydrolase gene from Pseudomonas diminuta. Bio/Technology, 3, 567–571.
   Google Scholar
• Sidell, F., & Groff, W. (1970). Toxigonin: Blood levels and side effects after intramuscular administration in man. Journal of Pharmaceutical Sciences, 59, 793–797.
   PubMed Web of Science ®Google Scholar
• Somani, S. M., Solana, R. P., & Dube, S. N. (1992). Toxicodynamics of nerve agents. In S. M Somani (Ed.), Chemical warfare agents (pp. 68–124). San Diego, CA: Academic.
   Google Scholar
• Sternberger, L. A., Cuculis, J. J., Meyer, H. G., Lenz, D. E., & Kavanagh, W. G. (1974). Antibodies to organophosphorus haptens: Immunity to paraoxon poisoning. Federation Proceedings, 33, 728.
   Google Scholar
• Sternberger, L. A., Sim, V. M., Kavanagh, W. G., Cuculis, J. J., Meyer, H. G., Lenz, D. E., et al. (1972). A vaccine against organophosphorus poisoning. Army Science Conference Proceedings, 3, 429–441.
   Google Scholar
• Stewart, W. C. (1959). The effects of sarin and atropine on the respiratory center and neuromuscular junctions of the rat. Canadian Journal of Biochemistry and Physiology, 37, 651–660.
   PubMedGoogle Scholar
• Stewart, W. C., & Anderson, E. A. (1968). Effects of a cholinesterase inhibitor when injected into the medulla of the rabbit. Journal of Pharmacology and Experimental Therapeutics, 162, 309–318.
   PubMed Web of Science ®Google Scholar
• Talbot, B. G., Anderson, D. R., Harris, L. W., Yarbrough, L. W., & Lennox, W. J. (1988). A comparison of in vivo and in vitro rates of aging of soman-inhibited erythrocyte acetylcholinesterase in different animal species. Drug and Chemical Toxicology, 11, 298–305.
   Web of Science ®Google Scholar
• Taylor, P. (1990). Anticholinesterase agents. In A. G Gilman, T. W. Rall, A. S. Nies, & P. Taylor (Eds.), The pharmacological basis of therapeutics (pp. 131–149). New York: Macmillan.
   Google Scholar
• Vieira, P., & Rajewsky, K. (1988). The half-lives of serum immunoglobulins in adult mice. European Journal of Immunology, 18, 313–316.
   PubMed Web of Science ®Google Scholar
• Vojvodic, V. (1970). Blood levels, urinary excretion and potential toxicity of N,N'-trimethylenebis-(pyridinium-4-aldoxime) dichloride (TMB-4) in healthy men following intramuscular injection of the oxime. Clinical Pharmacology, 2, 216–220.
   Google Scholar
• Wenger, G. R. (1979). Effects of physostigmine, atropine and scopolamine on behavior maintained by a multiple schedule of food presentation in the mouse. Journal of Pharmacology and Experimental Therapeutics, 209, 137–143.
   PubMed Web of Science ®Google Scholar
• Wiezorek, W., Kreisel, W., Schnitzlein, W., & Matzkowski, H. (1968). Eigenwirkungen von Trimedoxin und Pralidoxim am Menschen [Specific effects of trimedoxin and pralidoxim on humans]. Zeitschrift Militarmedizine, 4, 223–226.
   Google Scholar
• Wilson, I. B., & Ginsburg, S. (1955). A powerful reactivator of alkyl phosphate-inhibited acetylcholinesterase. Biochimica et Biophysica Acta, 18, 168–170.
   PubMed Web of Science ®Google Scholar
• Wolfe, A. D., Blick, D. W., Murphy, M. R., Miller, S. A., Gentry, M. K., Hartgraves, S. L., et al. (1992). Use of cholinesterases as pretreatment drugs for the protection of rhesus monkeys against soman toxicity. Toxicology and Applied Pharmacology, 117, 189–193.
   PubMed Web of Science ®Google Scholar
• Wolfe, A. D., Rush, R. S., Doctor, B. P., Koplovitz, I., & Jones, D. (1987). Acetylcholinesterase prophylaxis against organophosphate toxicity. Fundamental and Applied Toxicology, 9, 266–270.
   PubMedGoogle Scholar
• Yli-Kauhaluoma, J., Humppi, T., & Yliniemela, A. (1999). Hydrolysis of organophosphorus nerve agent soman by the monoclonal antibodies elicited against an oxyphosphorane hapten. Acta Chemica Scandinavica, 53, 473–479.
   PubMedGoogle Scholar